3
Announcements
Trials
Browse
Landscape
Status
Completed
1
Sponsor Class
OTHER_GOV
1
Study Type
Observational
1
Sponsor
Cancer Type
Gynecologic
1
Conditions
Carcinoma, Non-Small-Cell Lung
5
Endometrial Neoplasms
3
Breast Neoplasms
3
Ovarian Neoplasms
2
Non Small Cell Lung Carcinoma NSCLC
2
Neoplasms
2
Neoplasm Metastasis
2
Uterine Cervical Neoplasms
1
Urologic Neoplasms
1
Urogenital Neoplasms
1
Squamous Cell Carcinoma of Head and Neck
1
Sarcopenia
1
Penile Neoplasms
1
Non-Small Cell Lung Cancer With HER2- Mutations
1
Malnutrition
1
Male Urogenital Diseases
1
Lung Neoplasms
1
First-line Advanced NSCLC Patients
1
Fallopian Tube Neoplasms
1
Dysgeusia
1
Carcinoma
1
Interventions
Paclitaxel
43
Carboplatin
38
Bevacizumab
29
liposomal doxorubicin
20
Taxes
19
Specimen Handling
18
pembrolizumab
17
olaparib
17
Magnetic Resonance Spectroscopy
16
Gemcitabine
16
Topotecan
14
Immunoglobulin G
12
Disulfides
12
Biopsy
11
niraparib
8
mirvetuximab soravtansine
8
Nivolumab
8
Doxorubicin
8
Cyclophosphamide
6
Cisplatin
6
Drug Therapy
5
130-nm albumin-bound paclitaxel
5
cemiplimab
4
cediranib
4
Letrozole
4
Ipilimumab
4
Injections
4
Docetaxel
4
1-dodecylpyridoxal
4
sarilumab
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Fallopian Tube Neoplasms
×
CP protocol
×
1 year
×
Clear all
NCT07154966
2025-09-04
GYM-TASTE
Ankara Etlik City Hospital
Completed
102 enrolled